BERLIN (Reuters) – German medicine container maker Schott Pharma is no longer seeking a strategic investor and now plans to float part of the company while leaving the existing owners in control, its chief executive told the Frankfurter Allgemeine newspaper.
The Mainz, western Germany-based company is one of the world’s largest makers of glass and plastic containers used for medicines and vaccines, selling some 13 billion ampules, syringes and phials each year.
“Now, we’re only looking to a flotation,” Chief Executive Frank Heinricht was quoted as saying on Tuesday.
The company’s turnover rose 27% last year to 821 million euros.
(Reporting by Thomas Escritt; Editing by Bernadette Baum)
